Replies to post #4344 on P10 Industries Inc. (PX)

[paideia]

Well, if it's large shareholders bailing on a company after a failed drug trial that renders hundreds of millions of dollars in NOLs worthless, wouldn't it be smart and profitable to only bail on 49% of the company? They might use ACXW/PIOE as a case study!

In most cases biotech companies will undergo one or more Ownership Changes after a drug fails and larger shareholders bail out. Once this happens, it is almost impossible to remedy the NOL usage limitation.

[chemist72]

and their indemnification has value

May be a silly question, but how much is indemnification worth? Can it be quantified easily or not? - TIA

P.S. I'm not a business person but rather a scientist. Which is also why I'm having trouble understanding how to value PIOE's NOL's. Oh well, maybe in my next life I will get into business and/or accounting as math was always one of my favorite subjects. lol